















































































































































































































Chapter 1: Introduction 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.8 The in vivo reservoir and eradication studies 
	
1.8.1 Measures of the latent reservoir in vivo 
	






































































































































































































































































































































2.2 RNA extraction and reverse transcription 

























































































































































2.6 Cell culture 


































































































































































































2.9 Detection of protein by western blot 























































































Chapter 3: The effect of combinations 
of latency reversing agents in the J-lat 




































































































































































































































3.4 Stimulation of J-lat clones with panobinostat in combination with other 











































































































































































Chapter 4: Investigating the role of 
HUSH mediated recruitment of SETDB1 






























































































































4.3 Transduction of cells with shRNA expressing vector 






















































4.4 The effect of HUSH knockdown in J-lat cells 



























































































































































































































































































































































Chapter 5: The effect of mutations in 

























































































































































































































































































































































































































































































































Chapter 6: Summary and concluding 
thoughts 
HIV	infection	remains	a	global	public	health	problem.		The	present	treatment	
involving	patients	taking	life	long	suppressive	medication	has	achieved	impressive	
results	in	terms	of	quality	of	life	and	prognosis	for	those	who	are	able	to	access	
antiretroviral	therapy.		Nonetheless	the	global	prevalence	of	this	infection	has	
continued	to	increase,	driven	by	a	combination	of	new	infections	and	increased	
survival	of	those	infected.		The	economic	burden	in	countries	with	large	
populations	of	people	living	with	HIV	is	considerable.		The	ability	to	eradicate	the	
virus	from	an	individual	would	be	a	powerful	tool	in	reversing	this	situation.	
	
As	discussed	in	Chapter	1	there	is	reason	to	think	that	the	principal	barrier	to	a	
cure	are	latently	infected	CD4+	T	cells.		In	this	thesis	the	mechanisms	maintaining	
latency	as	well	as	factors	which	influence	the	efficiency	of	waking	virus	have	been	
examined.		In	Chapter	3	a	cell	line	model	of	latency	was	used	to	examine	how	
clones	of	latently	infected	cells	harbouring	a	provirus	in	an	identical	integration	
site	might	respond	to	agents	designed	to	provoke	transcription	and	reverse	
latency.		It	was	observed	that	only	a	proportion	of	cells	within	a	clone	respond	to	
each	stimulation	and	that	this	maximum	proportion	is	fixed	for	each	integration	
site	and	activating	agent	combination.		In	addition	it	was	possible	to	show	that	
these	fixed	upper	limits	could	be	overcome	by	utilising	combinations	of	latency	
reversing	agents.		These	observations	provide	insights	into	how	best	to	shrink	the	
reservoir	of	latently	infected	cells;	particularly	in	light	of	emerging	evidence	of	
clonal	proliferation	of	infected	cells	in	vivo.		
	
In	Chapter	4	the	potential	role	of	a	recently	described	protein	complex	(HUSH)	in	
promoting	latency	was	examined.		This	yielded	mixed	results;	it	was	not	possible	
to	demonstrate	that	HUSH	had	a	significant	contribution	to	the	silencing	of	most	
clones	in	the	J-lat	model	of	latency.		Some	of	the	data	here	suggest	that	HUSH	may	
have	a	role	in	early	establishment	of	silencing	however	the	results	were	not	able	
to	demonstrate	this	conclusively.		Taken	together	with	the	results	reported	by	the	
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Lehner	lab	HUSH	may	be	involved	in	specific	contexts	which	were	not	fully	
explored	in	this	chapter.	
	
In	Chapter	5	the	contribution	of	viral	factors	to	the	silencing	of	HIV	proviruses	was	
examined.		Polymorphisms	in	a	recently	described	splice	enhancer	were	used	as	a	
model	to	examine	the	paradigm	that	variations	in	the	Tat-TAR	axis	driving	HIV	
transcription	could	influence	the	rate	of	silencing.		Mutations	which	had	a	
deleterious	effect	on	splicing	Tat	mRNA	were	observed	to	promote	HIV	silencing	
while	only	having	a	moderate	effect	on	the	ability	of	the	virus	to	replicate.		These	
mutations	also	altered	the	threshold	at	which	stimulation	would	induce	
transcription	from	a	silenced	provirus.		This	has	important	consequences	for	
understanding	how	the	reservoir	is	structured	in	vivo	and	suggests	that	some	cells	
may	harbour	viruses	requiring	greater	stimulation	to	induce	expression.		This	in	
turn	may	provide	some	explanation	for	the	observation	reported	by	the	Siliciano	
group	that	some	cells	in	vivo	harbour	apparently	intact	proviruses	from	which	
transcription	cannot	be	induced.	
	
The	data	here	also	suggest	avenues	for	future	investigation	especially	in	
examining	cells	ex	vivo.		Data	concerning	the	behaviour	of	clonally	integrated	
proviruses	in	patients	is	scarce.		Were	it	possible	to	identify	and	maintain	a	clone	
from	a	patient	than	it	would	be	instructive	to	replicate	the	experiments	here.		A	an	
alternate	approach	would	be	to	take	a	longitudinal	look	at	changes	in	the	
phylogeny	of	the	HIV	reservoir	in	patients	receiving	a	HDACi	or	other	latency	
reversing	agent.		A	differential	change	in	the	representation	of	one	clone	over	
another	would	suggest	that	there	is	a	corresponding	difference	in	sensitivity	to	
latency	reversal	between	to	two	clones.	
	
Further	work	on	viral	factors	contributing	to	latency	is	needed.		An	obvious	
starting	point	would	be	to	examine	how	polymorphisms	in	the	LTR	and	in	the	
coding	of	Tat	affect	transcription	and	silencing	in	a	similar	way	to	the	ESEtat	
mutants	studied	here.		Another	approach	would	be	a	comparison	of	the	sequences	
of	viruses	successfully	reactivated	from	primary	cells	to	those	of	intact	non-
induced	proviruses	to	identify	sequences	which	are	over	represented	in	the	latent	
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viruses.		Clearly	this	approach	would	require	a	large	data	set	however	the	rapid	
pace	of	advances	in	sequencing	technology		in	combination	with	the	ongoing	
interest	in	publishing	sets	of	these	sequences	will	make	this	comparison	feasible	
in	the	near	future.	
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